Clinical Trials in New York State

Showing 13941-13960 of 14,718 trials

Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy

NCT00083486

The purpose of this study is to determine the effectiveness of different doses of epoetin alfa for treating anemia in patients who have cancer; or patients who no longer have any signs of cancer, but remain anemic as a result of their treatment. These patients should not be currently receiving chemotherapy or radiotherapy. A subject's participation in the study will last approximately 6 months. Subjects will receive weekly doses of epoetin alfa or placebo. Their hemoglobin will be tested every week.

Anemia

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Started Feb 2004

Hot Springs, Arkansas, United States • Griffin, Georgia, United States • Centralia, Illinois, United States +9 more locations

COMPLETEDPhase 269 miles

Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment

NCT00004584

The purpose of this study is to look at the safety and effectiveness of an experimental protease inhibitor (a type of anti-HIV drug) called BMS-232632. Doctors will compare an anti-HIV drug combination that includes BMS-232632 to a drug combination that includes ritonavir.

HIV Infections

Bristol-Myers SquibbStarted Dec 1999

Birmingham, Alabama, United States • Los Angeles, California, United States • Oakland, California, United States +35 more locations

Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy

Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment

Find Trials by Condition in New York State

Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation

Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer

Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen

Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing Regimen

A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn

A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Sinus Infections in Adults

Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)

"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"

The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine

An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload

Chart Review of Antivirals for Influenza in Infants

Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU)

Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment

Hypertonic Resuscitation Following Severe Traumatic Brain Injury (TBI)

Intra-Cardiac Echocardiography Guided Cardioversion(ICE-CHIP) Study

A Study to Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6-17 Years of Age

TENS Effectiveness and Knee Osteoarthritis in Humans